Recorded Chinese product: 氯化琥珀胆碱注射液氯化琥珀胆碱注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

琥珀胆碱是一种在国家药监局注册认定的药品。标注生产企业为上海旭东海普药业有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司、上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司、上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 氯化琥珀胆碱注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 上海旭东海普药业有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司, 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司, 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 氯化琥珀胆碱注射液Recorded Chinese product: 氯化琥珀胆碱注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 2ml:100mg2 mL:100 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31020599

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31020599

Manufacturer

Chinese legal name: 上海旭东海普药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31020599

生产企业

上海旭东海普药业有限公司(国产)

适应症

去极化型骨骼肌松弛药。可用于全身麻醉时气管插管和术中维持肌松。

用法用量

本品必须在具备辅助或控制呼吸的条件下使用:1.气管插管时,1~1.5mg/kg,最高2mg/kg;小儿1~2mg/kg,用0.9%氯化钠注射液稀释到每ml含10mg,静脉或深部肌内注射,肌内注射一次不可超过150mg。2.维持肌松:一次150~300mg溶于500ml5%~10%葡萄糖注射液或1%盐酸普鲁卡因注射液混合溶液中静脉滴注。

不良反应

1.高血钾症本品引起肌纤维去极化时使细胞内K+迅速流至细胞外。正常人血钾上升0.2~0.5mmol/L;严重烧伤、软组织损伤、腹腔内感染、破伤风、截瘫及偏瘫等,在本品作用下引起异常的大量K+外流致高血钾症,产生严重室性心律失常甚至心搏停止。2.心脏作用本品的拟乙酰胆碱作用可引起心动过缓、结性心律失常和心搏骤停,尤其是重复大剂量给药最易发生。3.眼内压升高本品对眼外肌引起痉挛性收缩以致眼压升高。4.胃内压升高最高可达40cmH2O,并可引起饱胃病人胃内容反流误吸。5.恶性高热多见于本品与氟烷合用的病人;也多发生于小儿。6.术后肌痛给药后卧床休息者肌痛轻而少,1~2天内即起床活动者肌痛剧而多。7.可能导致肌张力增强以胸大肌最为明显,其次是腹肌,严重时波及肱二头肌和股四头肌等。这时不仅机体总的氧耗量加大,足以引起胃内压甚至颅内压升高。

禁忌

1.脑出血、青光眼、视网膜剥离、白内障摘除术、低血浆胆碱酯酶、严重创伤大面积烧伤、上运动神经元损伤的病人及高钾血症患者禁用。


2.使用抗胆碱酯酶药者慎用。

注意事项

1.不具备控制或辅助呼吸条件时,严禁使用。2.忌在病人清醒下给药。3.严重肝功能不全、营养不良、晚期癌症、严重贫血、年老体弱、严重电解质紊乱等患者慎用。4.接触有机农药患者,已证明无血浆胆碱酯酶减少或抑制者,方能使用至足量。5.为了解除本品肌松作用引起的短暂纤维颤动,可预先静脉注射小剂量非去极化肌松药(维库溴铵0.5mg)。6.预先给予阿托品可防止本品对心脏的作用。7.出现长时间呼吸停止,必须用人工呼吸,亦可输血,注射干血浆或其他拟胆碱酯酶药,但不可用新斯的明。

贮藏

遮光,密闭保存。

规格

2ml:100mg

证据Evidence

  • 批准文号: 国药准字H31020599
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.